190 related articles for article (PubMed ID: 28684541)
41. Advances in mitotic inhibitors for cancer treatment.
Jiang N; Wang X; Yang Y; Dai W
Mini Rev Med Chem; 2006 Aug; 6(8):885-95. PubMed ID: 16918495
[TBL] [Abstract][Full Text] [Related]
42. The balance between mitotic death and mitotic slippage in acute leukemia: a new therapeutic window?
Ghelli Luserna di Rorà A; Martinelli G; Simonetti G
J Hematol Oncol; 2019 Nov; 12(1):123. PubMed ID: 31771633
[TBL] [Abstract][Full Text] [Related]
43. Depletion of Survivin suppresses docetaxel-induced apoptosis in HeLa cells by facilitating mitotic slippage.
Han TL; Sha H; Ji J; Li YT; Wu DS; Lin H; Hu B; Jiang ZX
Sci Rep; 2021 Jan; 11(1):2283. PubMed ID: 33504817
[TBL] [Abstract][Full Text] [Related]
44. The flavonoid eupatorin inactivates the mitotic checkpoint leading to polyploidy and apoptosis.
Salmela AL; Pouwels J; Kukkonen-Macchi A; Waris S; Toivonen P; Jaakkola K; Mäki-Jouppila J; Kallio L; Kallio MJ
Exp Cell Res; 2012 Mar; 318(5):578-92. PubMed ID: 22227008
[TBL] [Abstract][Full Text] [Related]
45. Gene expression and mitotic exit induced by microtubule-stabilizing drugs.
Chen JG; Yang CP; Cammer M; Horwitz SB
Cancer Res; 2003 Nov; 63(22):7891-9. PubMed ID: 14633718
[TBL] [Abstract][Full Text] [Related]
46. Mitotic slippage and expression of survivin are linked to differential sensitivity of human cancer cell-lines to the Kinesin-5 inhibitor monastrol.
Asraf H; Avunie-Masala R; Hershfinkel M; Gheber L
PLoS One; 2015; 10(6):e0129255. PubMed ID: 26035434
[TBL] [Abstract][Full Text] [Related]
47. Adapt or die: how eukaryotic cells respond to prolonged activation of the spindle assembly checkpoint.
Rossio V; Galati E; Piatti S
Biochem Soc Trans; 2010 Dec; 38(6):1645-9. PubMed ID: 21118141
[TBL] [Abstract][Full Text] [Related]
48. Cell death response to anti-mitotic drug treatment in cell culture, mouse tumor model and the clinic.
Shi J; Mitchison TJ
Endocr Relat Cancer; 2017 Sep; 24(9):T83-T96. PubMed ID: 28249963
[TBL] [Abstract][Full Text] [Related]
49. Induction of C-anaphase and diplochromosome through dysregulation of spindle assembly checkpoint by sodium arsenite in human fibroblasts.
Yih LH; Lee TC
Cancer Res; 2003 Oct; 63(20):6680-8. PubMed ID: 14583462
[TBL] [Abstract][Full Text] [Related]
50. Cell fate determination in cisplatin resistance and chemosensitization.
Luong KV; Wang L; Roberts BJ; Wahl JK; Peng A
Oncotarget; 2016 Apr; 7(17):23383-94. PubMed ID: 26993599
[TBL] [Abstract][Full Text] [Related]
51. Perturbing mitosis for anti-cancer therapy: is cell death the only answer?
Haschka M; Karbon G; Fava LL; Villunger A
EMBO Rep; 2018 Mar; 19(3):. PubMed ID: 29459486
[TBL] [Abstract][Full Text] [Related]
52. [Antimicrotubule agents can activate different apoptotic pathways].
Kisurina-Evgen'eva OP; Briantseva SA; Stil' AA; Onishchenko GE
Biofizika; 2006; 51(5):875-9. PubMed ID: 17131827
[TBL] [Abstract][Full Text] [Related]
53. Targeting mitotic exit for cancer treatment.
Wäsch R
Expert Opin Ther Targets; 2011 Jul; 15(7):785-8. PubMed ID: 21476883
[TBL] [Abstract][Full Text] [Related]
54. SIRT2 knockdown increases basal autophagy and prevents postslippage death by abnormally prolonging the mitotic arrest that is induced by microtubule inhibitors.
Inoue T; Nakayama Y; Li Y; Matsumori H; Takahashi H; Kojima H; Wanibuchi H; Katoh M; Oshimura M
FEBS J; 2014 Jun; 281(11):2623-37. PubMed ID: 24712640
[TBL] [Abstract][Full Text] [Related]
55. Radiation-induced cellular senescence results from a slippage of long-term G2 arrested cells into G1 phase.
Ye C; Zhang X; Wan J; Chang L; Hu W; Bing Z; Zhang S; Li J; He J; Wang J; Zhou G
Cell Cycle; 2013 May; 12(9):1424-32. PubMed ID: 23574719
[TBL] [Abstract][Full Text] [Related]
56. Bcl-xL activity influences outcome of the mitotic arrest.
Suleimenov M; Bekbayev S; Ten M; Suleimenova N; Tlegenova M; Nurmagambetova A; Kauanova S; Vorobjev I
Front Pharmacol; 2022; 13():933112. PubMed ID: 36188556
[TBL] [Abstract][Full Text] [Related]
57. Brd4 is required for recovery from antimicrotubule drug-induced mitotic arrest: preservation of acetylated chromatin.
Nishiyama A; Dey A; Miyazaki J; Ozato K
Mol Biol Cell; 2006 Feb; 17(2):814-23. PubMed ID: 16339075
[TBL] [Abstract][Full Text] [Related]
58. Targeting mitotic pathways for endocrine-related cancer therapeutics.
Agarwal S; Varma D
Endocr Relat Cancer; 2017 Sep; 24(9):T65-T82. PubMed ID: 28615236
[TBL] [Abstract][Full Text] [Related]
59. Mitotic slippage underlies the relationship between p53 dysfunction and the induction of large micronuclei by colcemid.
Hashimoto K; Todo T
Mutagenesis; 2013 Jul; 28(4):457-64. PubMed ID: 23702691
[TBL] [Abstract][Full Text] [Related]
60. Assessment of cell cycle progression and mitotic slippage by videomicroscopy.
Mattiello L; Soliman Abdel Rehim S; Manic G; Vitale I
Methods Cell Biol; 2024; 181():43-58. PubMed ID: 38302243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
